1. Home
  2. Analysis

Haematuria and drugs of ingredients of rasburicase (a real world drug study)


Summary:

Haematuria is found among people who take drugs with ingredients of rasburicase, especially for people who are female, 10-19 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 2,616 people who have side effects when taking drugs with ingredients of rasburicase from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Elitek.

On Jul, 31, 2026

2,616 people reported to have side effects when taking drugs with ingredients of rasburicase.
Among them, 13 people (0.5%) have Haematuria

What is Haematuria?

Haematuria (presence of blood in urine) is found to be associated with 1,702 drugs and 2,525 conditions by eHealthMe. Check the latest studies of Haematuria.

Number of reports submitted per year:

Could drugs with ingredients of rasburicase cause Haematuria?

Time on drugs with ingredients of rasburicase when people have Haematuria *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haematuria when taking drugs with ingredients of rasburicase *:

  • female: 63.64 %
  • male: 36.36 %

Age of people who have Haematuria when taking drugs with ingredients of rasburicase *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 63.64 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 9.09 %
  • 50-59: 18.18 %
  • 60+: 9.09 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 30.77%
  2. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 4 people, 30.77%
  3. High Blood Pressure: 2 people, 15.38%
  4. Urinary Tract Infection: 2 people, 15.38%
  5. Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 15.38%
  6. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 2 people, 15.38%
  7. Asthma: 2 people, 15.38%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 15.38%
  9. Constipation: 2 people, 15.38%
  10. Fever: 2 people, 15.38%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Mephyton: 5 people, 38.46%
  2. Iressa: 4 people, 30.77%
  3. Lorazepam: 4 people, 30.77%
  4. Morphine: 4 people, 30.77%
  5. Fentanyl: 4 people, 30.77%
  6. Omeprazole: 4 people, 30.77%
  7. Ambisome: 3 people, 23.08%
  8. Ondansetron: 3 people, 23.08%
  9. Methotrexate: 2 people, 15.38%
  10. Paracetamol: 2 people, 15.38%

Other side effects people have besides Haematuria *:

You may use this to check any potential undetected side effects.

  1. Nausea And Vomiting: 5 people, 38.46%
  2. Nausea (feeling of having an urge to vomit): 4 people, 30.77%
  3. Oral Intake Reduced: 4 people, 30.77%
  4. Haematemesis (vomiting of blood): 4 people, 30.77%
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 23.08%
  6. Septic Shock (shock due to blood infection): 3 people, 23.08%
  7. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 23.08%
  8. Renal Disorder (kidney disease): 3 people, 23.08%
  9. Pleural Effusion (water on the lungs): 3 people, 23.08%
  10. High Blood Pressure: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of rasburicase, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on rasburicase. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.